USFDA completes inspection of Lupin’s Nagpur facility

08 Aug 2019 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection carried out at Lupin’s Nagpur oral solid manufacturing facility. The inspection was carried out between August 5, 2019 and August 8, 2019. The inspection for the oral solid facility at Nagpur closed without any 483 observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×